Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5471]
News [12782]
Articles [183]
Editorials [5]
Conferences [249]
elearning [17]
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated...
Nanotech turns pro-tumour immune cells into cancer-killing triple agents
Nanotech turns pro-tumour immune cells into cancer-killing triple agents
FDA approves daratumumab for transplant-eligible multiple myeloma
FDA approves daratumumab for transplant-eligible multiple myeloma
The hidden suffering of women with breast cancer in Gaza
The hidden suffering of women with breast cancer in Gaza
ESMO 2019: First targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial
ESMO 2019: First targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial
ESMO 2019: Targeted therapy slows progression of advanced prostate cancer
ESMO 2019: Targeted therapy slows progression of advanced prostate cancer
ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer
ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer
ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
ESMO 2019: New combination therapy offers bowel cancer patients extra treatment option
ESMO 2019: New combination therapy offers bowel cancer patients extra treatment option
ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer
ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation